P.O. Box 959
285 articles with AmerisourceBergen Corporation
The Board of Directors of AmerisourceBergen Corporation declared a quarterly cash dividend of $0.40 per common share, payable March 4, 2019, to stockholders of record at the close of business on February 19, 2019.
Revenues of $45.4 Billion for the First Quarter, a 12.2 Percent Increase Year-Over-Year
Today, AmerisourceBergen, a global healthcare solutions leader, announced the appointment of Silvana Battaglia to its executive team as Executive Vice President and Chief Human Resources Officer.
Safe Rx today announced its product availability in AmerisourceBergen, with merchandising kits available to all AmerisourceBergen California customers.
AmerisourceBergen Corporation today announced that it plans to release its results for the First Quarter Fiscal 2019 on Thursday, January 31, 2019, prior to the opening of trading on the New York Stock Exchange.
Michigan Healthcare Professionals Joins ION Solutions GPO Network & Selects Oncology Supply as Exclusive Specialty Distributor
AmerisourceBergen, a global healthcare solutions leader, today announced that Michigan Healthcare Professionals (MHP) has selected ION Solutions for GPO contracting and Oncology Supply for exclusive specialty distribution.
AmerisourceBergen's Pharmacy Check-Up Survey and Ambulatory Outlook for Health System Pharmacies Report Find Opportunities for Health System Pharmacists to Play a Greater Role in Healthcare
Nearly 80 percent of hospital pharmacists look forward to a greater role in healthcare and are well positioned to take on an expanded role, according to new research sponsored by AmerisourceBergen.
US Bioservices Selected by Bayer and Its Collaboration Partner Loxo Oncology, Inc. to Dispense Vitrakvi® (larotrectinib)
New therapy approved to treat gene fusions across several different types of tumors
Investments will enhance customer experience and specialty transportation services through advanced technology solutions
AmerisourceBergen Foundation Donates Nearly 1 Million Drug Deactivation Resources and Provides Funding to 20+ Organizations to Help Combat the Opioid Epidemic
AmerisourceBergen has also distributed nearly one million drug deactivation resources through its Safe Disposal Support Program to 44 states and 140 organizations across the U.S.
UK-based subsidiaries Centaur Services, St Francis Group, Vetswest and Vet Space now part of MWI Animal Health offering
Revenues of $43.3 Billion for the Fourth Quarter, a 10.7 Percent Increase Year-Over-Year
AmerisourceBergen released the following comment regarding the signing of Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (“SUPPORT”) for Patients and Communities Act (H.R. 6) passed by the U.S. House of Representatives on Sept. 28, the U.S. Senate on Oct. 3, and signed into law today by President Trump during a ceremony at the White House.
Assessments by AmerisourceBergen, Cardinal Health, and McKesson Pharmaceutical Shows Nearly 80 Percent of Suppliers' Packages Do Not Meet Requirements
AmerisourceBergen Corporation today announced that it plans to release its results for the Fourth Quarter Fiscal 2018 on Tuesday, November 6, 2018, prior to the opening of trading on the New York Stock Exchange.
Good Neighbor Pharmacy Receives “Highest in Customer Satisfaction with Chain Drug Store Pharmacies” from J.D. Power
This marks the seventh time that Good Neighbor Pharmacy has earned the achievement in the last nine years.
Vineti partners with World Courier to provide state-of-the-art supply chain solution for global cell and gene therapy ecosystem
Vineti's leading digital "platform of record" for next-generation therapies, integrating with World Courier's global specialty logistics solution, supports commercial- and clinical-phase personalized medicines world-wide.
The U.S. District Court for the District of Alaska granted Bernie’s Pharmacy, Inc. motion for preliminary injunction, enjoining AmerisourceBergen Drug Corp. from terminating the supply of controlled substances to Bernie’s.
IntrinsiQ Specialty Solutions’ New MarketTREND Tool Provides Unparalleled Market Analysis Reports to Manufacturers
Drug manufacturers now have timely insights into utilization and market share of new products
US Bioservices Selected by Alnylam Pharmaceuticals as a Specialty Pharmacy Partner for ONPATTRO™ (patisiran)
Specialty pharmacy to support bringing new FDA-approved medicine to patients